Criteria | A: Early development | B: Early development | C: Late phase III | D: Post-marketing |
---|---|---|---|---|
Cost | 12.38 | 10.36 | Â | Â |
Sample Size | 11.76 | 12.91 | Â | 14.01 |
Study duration (time needed) | 12.10 | 13.18 | Â | 14.36 |
Low frequency of sessions | 5.45 | 4.21 | – | – |
A low cognitive load on patients | 8.21 | 4.35 | – | – |
Quick sessions with participants | – | 2.04 | – | – |
Complexity of instructions to participants | – | 3.78 |  | – |
Group dynamic with participants | – | – | 1.95 | – |
No interaction between participants (Solitarily exercise) | – | – | 3.80 | – |
Ease to which new attributes can be added without making prior results invalid | 2.91 | 2.75 | 2.92 | – |
Estimating weights for attributes | 4.60 | 3.59 | 6.45 | 4.04 |
Estimating trade-offs between attributes | 5.48 | 6.18 | 9.31 | 5.98 |
8 or more attributes can be explored | – | – | – | 1.89 |
Degree to which internal validation methods can be incorporated | 7.16 | 8.87 | 12.89 | 7.57 |
Degree to which external validity is established | 10.15 | 8.00 | 11.72 | 11.62 |
Exploring the reasons behind a preference in qualitative detail | 8.00 | 9.01 | 6.09 | 4.91 |
Public acknowledgement by your organisation as an acceptable method to study preferences | – | – | 6.15 | 4.27 |
Quantifying heterogeneity in preferences | 6.94 | 6.62 | 13.2 | 9.02 |
Calculating of risk attitudes (like risk tolerance vs. risk aversion) due to uncertainty in the value of an attribute | 4.87 | 4.18 | 8.36 | 6.85 |